<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>405</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15706605</PubmedId>
            <Abstract>Phage display technologies have been increasingly utilized for the generation of therapeutic, imaging and purification reagents for a number of biological targets. Using a variety of different approaches, we have developed antibodies with high specificity and affinity for various targets ranging from small peptides to large proteins, soluble or membrane-associated as well as to activated forms of enzymes. We have applied this approach to G-protein coupled receptors (GPCRs), often considered difficult targets for antibody therapeutics and targeting. Here we demonstrate the use of this technology for the identification of human antibodies targeting C5aR, the chemoattractant GPCR receptor for anaphylatoxin C5a. The N-terminal region (residues 1-31) of C5aR, one of the ligand binding sites, was synthesized, biotinylated and used as the target for selection. Three rounds of selection with our proprietary human Fab phage display library were performed. Screening of 768 isolates by phage ELISA identified 374 positive clones. Based on sequence alignment analysis, the positive clones were divided into 22 groups. Representative Fab clones from each group were reformatted into IgGs and tested for binding to C5aR-expressing cells, the differentiated U-937 cells. Flow cytometric analysis demonstrated that nine out of 16 reformatted IgGs bound to cells. Competition with a C5aR monoclonal antibody S5/1 which recognizes the same N-terminal region showed that S5/1 blocked the binding of positive cell binders to the peptide used for selections, indicating that the identified cell binding IgGs were specific to C5aR. These antibody binders represent viable candidates as therapeutic or imaging agents, illustrating that phage display technology provides a rapid means for developing antibodies to a difficult class of targets such as GPCRs.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>327-33</ArticlePages>
            <ArticleTitle>Discovery of human antibodies against the C5aR target using phage display technology.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Lili</ForeName>
                </Author>
                <Author>
                    <LastName>Sato</LastName>
                    <ForeName>Aaron K</ForeName>
                </Author>
                <Author>
                    <LastName>Sachdeva</LastName>
                    <ForeName>Meena</ForeName>
                </Author>
                <Author>
                    <LastName>Fleming</LastName>
                    <ForeName>Tony</ForeName>
                </Author>
                <Author>
                    <LastName>Townsend</LastName>
                    <ForeName>Susan</ForeName>
                </Author>
                <Author>
                    <LastName>Dransfield</LastName>
                    <ForeName>Daniel T</ForeName>
                </Author>
            </Authors>
            <Affiliations>Discovery Research, Dyax Corp., 300 Technology Square, Cambridge, MA 02139, USA. lhuang@dyax.com.</Affiliations>
            <ArticleChemicalList>C5AR1 protein, human;Immunoglobulin Fab Fragments;Immunoglobulin G;Membrane Proteins;Peptide Library;Receptor, Anaphylatoxin C5a;Receptors, Complement</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Cell Differentiation(drug effects); Humans; Immunoglobulin Fab Fragments(genetics; isolation &amp; purification; pharmacology); Immunoglobulin G(genetics; isolation &amp; purification; pharmacology); Membrane Proteins(immunology); Molecular Sequence Data; Peptide Library; Receptor, Anaphylatoxin C5a; Receptors, Complement(immunology); U937 Cells</ArticleMeshHeadingsList>
            <Journal>
                <Volume>18</Volume>
                <Issue>4</Issue>
                <Title>Journal of molecular recognition : JMR</Title>
                <Issn>0952-3499</Issn>
                <MedlineTa>J Mol Recognit</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>C5a N-terminal peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MNSFNYTTPDYGHYDDKDTLDLNTPVDKTSN</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>31</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P21730.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1A</LocationOfData>
                <EpitopeId>42238</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>31</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1and 2</LocationOfData>
                        <BCellId>7278</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Monoclonal antibodies were produced from human Fab phage display library constructed from autoimmune patients.  V-genes from autoimmune patients  (V&lt;sub&gt;L&lt;/sub&gt;C&lt;sub&gt;L&lt;/sub&gt; and V&lt;sub&gt;H&lt;/sub&gt;-CDR3) and synthetic V&lt;sub&gt;H&lt;/sub&gt;-CDR1/2 were cloned into phage display vector using oligonucleotide-assisted cleavage and ligation (ONCL).  Positive binders were subsequently reformatted to fully human IgGs for subsequent testing.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Fab400 Phage display library panning was carried using a dPEG4-biotin conjugate of the natural epitope 1-31 C5aR (CD88) denoted DX-1186.  An unconjugated and amidated peptide was used for elution during selection (DX-1185).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Displayed Ab(s)</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Display Library</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Fab400 library</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C5a N-terminal peptide</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MNSFNYTTPDYGHYDDKDTLDLNTPVDKTSN</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>31</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P21730.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>1037</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Antibodies were isolated from autoimmune human Fab phage display library, reformatted and expressed in HEK-293T cells.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>308</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>9 out of 16 reformatted IgGs were positive for binding to cells expressing C5aR.  Of these, six clones IgG-15, IgG-28, IgG-31, IgG-33, IgG-38, and IgG-43 demonstrated good binding.   Competition ELISA was performed with these six clones using C5aR monoclonal antibody S5/1 which recognizes the epitope.  mAb S5/1 blocked the binding of positive responders to the peptide."".</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>IgG-reformatted clones</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C5a N-terminal peptide</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MNSFNYTTPDYGHYDDKDTLDLNTPVDKTSN</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>31</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P21730.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 3 and 4</LocationOfData>
                        <BCellId>1036</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Antibodies were isolated from autoimmune human Fab phage display library, reformatted and expressed in HEK-293T cells.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>139</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Reformatted and humanized IgG clones were tested by FACS for their cell binding activities on C5aR-expressing cells. Binding of clones to undifferentiated U-397 cells was used as the control.  Promonocytic U-937 cells were terminally differentiated with Bt2cAMP for 3 days prior to assay.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>IgG-reformatted clones (multiple tested)</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Chemotactic C5a receptor</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P21730.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

